Cargando…
Interim Guidelines on Antiviral Therapy for COVID-19
Since the first case was reported in Wuhan, Hubei Province, China on December 12, 2019, Coronavirus disease 2019 (COVID-19) has spread widely to other countries since January 2020. As of April 16, 2020, 10635 confirmed cases have been reported, with 230 deaths in Korea. COVID-19 patients may be asym...
Autores principales: | Kim, Sun Bean, Huh, Kyungmin, Heo, Jung Yeon, Joo, Eun-Jeong, Kim, Youn Jeong, Choi, Won Suk, Kim, Yae-Jean, Seo, Yu Bin, Yoon, Young Kyung, Ku, Nam Su, Jeong, Su Jin, Kim, Sung-Han, Peck, Kyong Ran, Yeom, Joon Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335642/ https://www.ncbi.nlm.nih.gov/pubmed/32342676 http://dx.doi.org/10.3947/ic.2020.52.2.281 |
Ejemplares similares
-
Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19
por: Kim, Sun Bean, et al.
Publicado: (2021) -
Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19
por: Kim, Sun Bean, et al.
Publicado: (2021) -
Two Years of Experience and Methodology of Korean COVID-19 Living Clinical Practice Guideline Development
por: Choi, Miyoung, et al.
Publicado: (2023) -
Guidelines on Implementing Antimicrobial Stewardship Programs in Korea
por: Yoon, Young Kyung, et al.
Publicado: (2021) -
Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea
por: Jo, Youngji, et al.
Publicado: (2022)